Unknown

Dataset Information

0

The Protective Effect of Basic Fibroblast Growth Factor on Diabetic Nephropathy Through Remodeling Metabolic Phenotype and Suppressing Oxidative Stress in Mice.


ABSTRACT: Diabetic nephropathy is a common complication in diabetes, but still lack of effective therapeutic strategies. This study aimed to investigate the therapeutic effect of basic fibroblast growth factor (bFGF) in db/db mice with diabetic nephropathy and explore its possible metabolic mechanisms using a nuclear magnetic resonance-based metabolomic approach. We found that bFGF treatment significantly alleviate urinary albumin to creatinine ratio and renal fibrosis in db/db mice, suggesting a potential renal protective effect. Metabolomics results reveal that bFGF remodeled metabolic phenotypes of the kidney and urine in db/db mice, mainly involving energy metabolism, methylamine metabolism, osmoregulation, and oxidative stress. Furthermore, the results show that bFGF-induced reductions of oxidative stress and apoptosis in db/db mice might be mediated by NOX-ROS-Nrf2 signaling. Therefore, our study suggests that the protective effect of bFGF on diabetic nephropathy could be mediated by remodeling metabolic phenotype and suppressing oxidative stress.

SUBMITTER: Wei T 

PROVIDER: S-EPMC7046551 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Protective Effect of Basic Fibroblast Growth Factor on Diabetic Nephropathy Through Remodeling Metabolic Phenotype and Suppressing Oxidative Stress in Mice.

Wei Tingting T   Shu Qi Q   Ning Jie J   Wang Shuaijie S   Li Chen C   Zhao Liangcai L   Zheng Hong H   Gao Hongchang H  

Frontiers in pharmacology 20200221


Diabetic nephropathy is a common complication in diabetes, but still lack of effective therapeutic strategies. This study aimed to investigate the therapeutic effect of basic fibroblast growth factor (bFGF) in <i>db/db</i> mice with diabetic nephropathy and explore its possible metabolic mechanisms using a nuclear magnetic resonance-based metabolomic approach. We found that bFGF treatment significantly alleviate urinary albumin to creatinine ratio and renal fibrosis in <i>db/db</i> mice, suggest  ...[more]

Similar Datasets

| S-EPMC4390193 | biostudies-literature
2022-09-16 | E-MTAB-12135 | biostudies-arrayexpress
| S-EPMC7825565 | biostudies-literature
| S-EPMC5818994 | biostudies-literature
| S-EPMC5093531 | biostudies-literature
2004-04-01 | GSE1009 | GEO
| S-EPMC8064606 | biostudies-literature
| S-EPMC6738594 | biostudies-literature
| S-EPMC8542911 | biostudies-literature
2016-08-01 | E-GEOD-84908 | biostudies-arrayexpress